Current therapeutic strategies and challenges in NSCLC treatment: A comprehensive review

M Kumar, A Sarkar - Experimental oncology, 2022 - exp-oncology.com.ua
Non-small cell lung cancer (NSCLC) is one of the most lethal malignancies accountings for
nearly 80% of all lung cancer cases diagnosed and causing over one million deaths …

CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW.

M Kumar, A Sarkar - Experimental Oncology, 2022 - europepmc.org
Non-small cell lung cancer (NSCLC) is one of the most lethal malignancies accountings for
nearly 80% of all lung cancer cases diagnosed and causing over one million deaths …

[引用][C] CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW

M Kumar, A Sarkar - Experimental Oncology, 2022 - elibrary.ru

[PDF][PDF] CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW

M Kumar, A Sarkar - researchgate.net
Non-small cell lung cancer (NSCLC) is one of the most lethal malignancies accountings for
nearly 80% of all lung cancer cases diagnosed and causing over one million deaths …

CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW

M Kumar, A Sarkar - Experimental Oncology, 2023 - cir.nii.ac.jp
抄録< jats: p> Non-small cell lung cancer (NSCLC) is one of the most lethal malignancies
accountings for nearly 80% of all lung cancer cases diagnosed and causing over one million …

CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW

M Kumar, A Sarkar - Experimental oncology, 2022 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is one of the most lethal malignancies accountings for
nearly 80% of all lung cancer cases diagnosed and causing over one million deaths …